Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
06-08 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
06-08 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
14 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/kaerus-biosciences-lead-candidate-ker-0193-granted-orphan-drug-designation-and-rare-pediatric-drug-designation-by-us-fda-for-treatment-of-fragile-x-syndrome-fxs-302454471.html
11 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/11/3040590/0/en/Kaerus-Bioscience-Successfully-Completes-Phase-1-Trial-and-Demonstrates-Proof-of-Mechanism-with-its-Novel-BK-Channel-Modulator-KER-0193-being-developed-for-Fragile-X-Syndrome.html
ABOUT THIS PAGE